Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB) [Phase 2]
Phase II study evaluating the combination of tucatinib and ado-trastuzumab emtansine (T-DM1) in HER2-positive metastatic solid tumors with b…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases [NA]
This clinical trial update describes a feasibility study of a cognitive stepped-care program for adults with brain metastases, and the study…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: MeDex: No Perioperative Dexamethasone in Brain Metastases [NA]
The MeDex trial from the University of Louisville is evaluating outcomes when perioperative dexamethasone is not given to patients with brai…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies [Phase 1]
Phase 1 study update for DSB2455 assessing safety, tolerability, and activity in advanced HRD-associated cancers, including breast cancer, o…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases [Phase 2]
Phase 2 clinical trial update exploring Sacituzumab Tirumotecan with or without radiotherapy for EGFR-mutant non-small cell lung cancer with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis [NA]
This clinical trial is evaluating advanced magnetic resonance imaging to identify recurrent brain tumors and radiation necrosis, and it is c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex [NA]
This clinical trial update describes the use of navigated transcranial magnetic stimulation (nTMS) to plan stereotactic radiosurgery for pat…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study [Phase 2]
This document describes a randomized Phase II clinical trial evaluating intracavitary carrier-embedded Cesium-131 brachytherapy for recurren…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Assessment of Eloquent Function in Brain Tumor Patients
This trial update notes that a study evaluating eloquent function in patients with brain tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating natural killer cell therapy (UD TGFβi NK cells) in combination with temozolomide for patients with …
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain [Phase 2]
A Phase 2 trial evaluating low-dose ipilimumab in combination with pembrolizumab for metastatic melanoma with brain metastases has completed…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases [Phase 2]
Phase 2 clinical trial update from University of Zurich evaluating ex vivo drug response to guide next-generation care of brain metastases; …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours [NA]
This clinical trial update describes a brain metastases research platform aimed at addressing CNS metastases in solid tumors, sponsored by J…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer [Phase 1]
A Phase 1 trial evaluating tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery for brain metastases in HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Frameless Stereotactic Radiosurgery for Intact Brain Metastases [Phase 2]
A Phase 2 clinical trial is evaluating frameless stereotactic radiosurgery for intact brain metastases, and the study is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]
Phase 2 ascending-dose study of RVP-001, a manganese-based MRI contrast agent, completed to assess safety and preliminary efficacy in CNS le…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases [Phase 2]
A Phase 2 clinical trial is assessing furmonertinib in combination with intrathecal chemotherapy and stereotactic radiotherapy for EGFR-muta…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors [Phase 3]
This Phase 3 trial is evaluating pre-operative or post-operative stereotactic radiosurgery for patients with surgically resected metastatic …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating neuropsychological care to preserve quality of life after radiation therapy in patients with brain metasta…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study Assessing QBS72S For Treating Brain Metastases [Phase 2]
Stanford University is conducting a Phase 2 trial of QBS72S for brain metastases. The study lists brain metastases, breast cancer, lung canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing stereotactic radiosurgery with olaparib followed by durvalumab and physician's choice systemic therapy…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Asciminib in HER2+ Breast Cancer Brain Metastases [Phase 1, Phase 2]
A clinical trial update indicates Asciminib is being studied in HER2-positive metastatic breast cancer with brain metastases in Phase 1/Phas…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating two combination regimens for BRAFV600-mutant metastatic or unresectable melanoma: nivolumab with …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases [Phase 2]
Phase 2 clinical trial update on an anti-PD-1 therapy for melanoma with brain metastases; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases [Phase 1]
Phase 1 clinical trial evaluating the combination of stereotactic radiation and nivolumab for metastatic breast cancer with brain metastases…